Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000337025 | SCV000399349 | uncertain significance | Brittle cornea syndrome 1 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002328844 | SCV002636757 | uncertain significance | Cardiovascular phenotype | 2019-06-11 | criteria provided, single submitter | clinical testing | The p.S1497T variant (also known as c.4490G>C), located in coding exon 2 of the ZNF469 gene, results from a G to C substitution at nucleotide position 4490. The serine at codon 1497 is replaced by threonine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species, and threonine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |